Skip to Main Content

Paper Details

Diagnostic and therapeutic considerations in biopsy-proven type 2 autoimmune pancreatitis: comparative analysis with biopsy-proven type 1 autoimmune pancreatitis.
ANZ J Surg
4
2021
AIP, Autoimmune, Autoimmune pancreatitis, IgG4, Patients, Type 2 AIP, acute and chronic pancreatitis, autoimmune pancreatitis, inflammatory bowel disease, patients, recurrent pancreatitis, serum IgG4-negative, type, type 1 and 2, type 1 autoimmune pancreatitis, type 2 AIP, type 2 autoimmune pancreatitis

Datasets

Release 1.2